TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study.

Int J Cancer · 2025 · PMC12141980 · PMID 40098565

Europe PMC DOI

hedged sentence

0.1019

closest p · 2.0× alpha

0.1019

boldest claim

The sentences

did not reach statistical significancep = .1019not close (p > 0.1)

However, when the ROC analysis was restricted to the bitherapy cohort, the AUC was 0.736 but still did not reach statistical significance ( p = .1019), possibly due to the small number of patients included in this analysis ( n = 17).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.